Clinical Trials in Novara, Novara
2 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel
Triple Negative Breast Cancer Metastatic
IFOM ETS - The AIRC Institute of Molecular Oncology37 enrolled6 locationsNCT05582538
Recruiting
A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer
Breast Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology1,500 enrolled10 locationsNCT04625023
Recruiting
Not Applicable
Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)
Early Breast CancerNeoadjuvant Treatment
University of Eastern Piedmont160 enrolled1 locationNCT06928701